EVEZ Stock Overview
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Evolva Holding SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CHF 0.94 |
52 Week High | CHF 17.10 |
52 Week Low | CHF 0.62 |
Beta | 0.20 |
11 Month Change | -6.07% |
3 Month Change | 36.81% |
1 Year Change | -94.61% |
33 Year Change | -98.00% |
5 Year Change | -98.37% |
Change since IPO | -99.39% |
Recent News & Updates
Recent updates
Shareholder Returns
EVEZ | GB Chemicals | GB Market | |
---|---|---|---|
7D | 0% | -5.0% | -0.3% |
1Y | -94.6% | -18.5% | 6.1% |
Return vs Industry: EVEZ underperformed the UK Chemicals industry which returned -37% over the past year.
Return vs Market: EVEZ underperformed the UK Market which returned 0.6% over the past year.
Price Volatility
EVEZ volatility | |
---|---|
EVEZ Average Weekly Movement | 19.1% |
Chemicals Industry Average Movement | 5.5% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: EVEZ's share price has been volatile over the past 3 months.
Volatility Over Time: EVEZ's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 49 | n/a | www.evolva.com |
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature made ingredient via fermentation that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
Evolva Holding SA Fundamentals Summary
EVEZ fundamental statistics | |
---|---|
Market cap | CHF 7.28m |
Earnings (TTM) | -CHF 101.22m |
Revenue (TTM) | CHF 4.16m |
1.8x
P/S Ratio-0.1x
P/E RatioIs EVEZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EVEZ income statement (TTM) | |
---|---|
Revenue | CHF 4.16m |
Cost of Revenue | CHF 0 |
Gross Profit | CHF 4.16m |
Other Expenses | CHF 105.37m |
Earnings | -CHF 101.22m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -14.04 |
Gross Margin | 100.00% |
Net Profit Margin | -2,434.99% |
Debt/Equity Ratio | 0% |
How did EVEZ perform over the long term?
See historical performance and comparison